National Institutes of Health supports novel drug discovery research

Approximately $1.7 million in new funding from the National Institutes of Health will enable a multidisciplinary team of University of Illinois at Chicago researchers to build a reference library of bacteria to help scientists quickly identify bacterial strains and analyze their disease-fighting potential. 12th International Conference on Pharmaceutical Chemistry during May 20-21, 2019 at Berlin, Germany.  The conference emphasizes the theme “Exploring the Challenges in…

Robotic System could Reduce the Cost of Drug Discovery

Developing a new drug is expensive and time-consuming. One major challenge is the sheer number of experiments needed to prove a drug is safe. Literally thousands of experiments with each potential treatment represents a huge investment in time and money. Robotic systems might hold the key to reducing development costs and also speeding up the…

Fingerprint #drug screen test works on the living and deceased

A revolutionary #drug test developed from research carried out at the University of East Anglia can detect four classes of drugs in traces of sweat found in a #fingerprint. And the technology works on both the living and deceased. New research published in the Journal of Analytical Toxicology shows how the Intelligent Fingerprinting #Drug Screening System enables…

Opioid-Induced Constipation: A New Drug to Treat the Side Effects of Opioids

During the 2016 Super Bowl, an advertisement featured a man suffering from opioid-induced constipation. Superficially, the commercial appeared to raise awareness of a distressing condition and suggest a solution to the problem. On a deeper level, it kicked off a discussion on how opioid-induced constipation might be better addressed by first reducing the use of…

Scientists develop first non-antibiotic drug to treat tuberculosis in animals

Scientists at The University of Manchester have developed the first non-antibiotic drug to successfully treat tuberculosis in animals. 12th International Conference on Pharmaceutical Chemistry from May 20-21, 2019 at Berlin, Germany. For more details kindly visit www.meetingsint.com/conferences/pharmachemistry The team hope the compound -developed after 10 years of painstaking research will be trialed on humans within three…

Just 6 hours of sleep loss increases diabetes risk

The importance of sleep is well-known. A recent study enforces this by demonstrating that sleep deprivation might increase diabetes risk — after losing just 1 night of sleep. Sleep is undoubtedly one of physiology’s most mysterious but essential functions. We all need it, yet the exact reasons why it’s so important are still being debated….

Common painkiller poses risk to heart health

One of the most widely used painkillers may pose a threat to cardiovascular health. This is the main takeaway of new research, recently published in The BMJ. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used to alleviate pain. In fact, according to the National Institutes of Health (NIH), about 30 million people in the United States…

Increased fines prove that illegal tooth whitening does not pay

  Health experts are warning beauty therapists and anybody else who is not a dental professional not to perform tooth whitening in clinics and spas, following a recent surge of fines and prosecutions. Authorities are now clamping down on those carrying out tooth whitening illegally, and courts are increasing the severity of the fines and convictions being handed…

Fruit consumption lowered risk of complications in people with diabetes

Most of us know that eating fresh fruit and vegetables is good for our health. However, people diagnosed with diabetes may avoid fruit due to its high sugar content. New research investigates the health benefits of fresh fruit consumption among people with diabetes. The researchers examined the effects of fruit consumption on almost 500,000 people…

US approves MSD HIV drugs Delstrigo and Pifeltro

Delstrigo is a once-daily fixed-dose combination tablet of doravirine, lamivudine and tenofovir disoproxil fumarate, while Pifeltro is a new non-nucleoside reverse transcriptase inhibitor (NNRTI) to be administered in combination with other antiretroviral medicines. In DRIVE-AHEAD trial, 728 participants with no antiretroviral treatment history were randomized and received at least one dose of either Delstrigo or…